Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.
about
Plants Consumption and Liver HealthA Locking Mechanism Regulates RNA Synthesis and Host Protein Interaction by the Hepatitis C Virus PolymeraseNon-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-Aryl-3-heteroaryl-1,3-thiazolidin-4-one derivativesApplications of computer-aided approaches in the development of hepatitis C antiviral agents.Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.A highly sensitive and selective viral protein detection method based on RNA oligonucleotide nanoparticle.New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors.Structure-based discovery of pyrazolobenzothiazine derivatives as inhibitors of hepatitis C virus replication.Ethyl acetate extract of Wedelia chinensis inhibits tert-butyl hydroperoxide-induced damage in PC12 cells and D-galactose-induced neuronal cell loss in miceInhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt.Design and synthesis of L- and D-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase.Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors.2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymeraseAllosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development.Sex hormones and HCV: an unresolved mystery.Discovery of the 2-phenyl-4,5,6,7-Tetrahydro-1H-indole as a novel anti-hepatitis C virus targeting scaffold.Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents.Some hydrazones of 2-aroylamino-3-methylbutanohydrazide: synthesis, molecular modeling studies, and identification as stereoselective inhibitors of HIV-1.Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta albaNatural Compounds as Anticancer Agents Targeting DNA Topoisomerases.Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors.Mode of antibacterial activity of Eclalbasaponin isolated from Eclipta alba.Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells.
P2860
Q26801951-BEBE3E46-0F09-4FE9-A1D8-883D07F67436Q27486419-25DDDE15-7993-4D30-A47E-CA791BB27F88Q27487508-9B4922DE-9249-4DE7-AAD1-CFD39C6F5A2EQ30238530-0A2596BA-316B-4123-88AA-3175D8F50BC3Q33631936-330F7C2A-3BF8-446F-AF53-DE75F59A5F0FQ33874011-DB9ECD56-AFFD-4BD4-9D36-5AF88CB89F4EQ34372464-2C881C92-69D8-40FE-88AC-ED20D8693175Q34467694-5D720552-B9FF-4D72-82C4-B985E6B2ACE6Q34587192-A29B5A53-3BD2-48EA-B664-7C13F7643DB6Q34993625-F4F2DBFF-D6E7-4B06-AB7A-84E89552E919Q35785613-EEB68FEA-8A69-4355-8245-74D89EDAFC13Q36521016-30A38DB4-241B-4603-BE0B-D59177F50692Q36836821-AE1D66C7-C894-4D1A-96B2-F49845F872B5Q36850338-34C75837-EF0B-4C73-A69F-BC4F1720ED31Q37638410-24AF1611-67C5-41CD-9DF2-E2963E55C5B2Q37731812-A8A438F6-995C-4B6E-B401-899470CA73D7Q37894718-D01AB56D-A08A-4739-95FC-6B805FCC84CFQ38069609-15398B1A-3D3F-4AAC-8845-0F4814C78808Q38885160-4711FBDB-151E-49D5-AC7C-94599D5BD06DQ38910335-A299EA04-581C-476A-9B89-06C14E83F158Q39177383-D57D4C88-44F4-4549-BDDC-EB5E830CB99CQ39218058-D698B749-8934-4B3D-AD48-BC0C5E80021CQ39268320-685A5C27-10B4-4644-9410-ECE60B346B27Q39305667-A0CA3E5B-48CF-429A-855A-0D11AC09A2E9Q39487360-76FCDD7A-CD48-4746-9309-6DE42E60B2AEQ45184797-9FF66D7A-6A34-47EB-9DAF-0B55D9CFBE0CQ53372840-E580A239-466D-46FE-8ABD-7EA5D6D7DBC0
P2860
Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Identification and characteriz ...... CV NS5B polymerase inhibitors.
@ast
Identification and characteriz ...... CV NS5B polymerase inhibitors.
@en
type
label
Identification and characteriz ...... CV NS5B polymerase inhibitors.
@ast
Identification and characteriz ...... CV NS5B polymerase inhibitors.
@en
prefLabel
Identification and characteriz ...... CV NS5B polymerase inhibitors.
@ast
Identification and characteriz ...... CV NS5B polymerase inhibitors.
@en
P2093
P2860
P356
P1476
Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
@en
P2093
Alain Bopda-Waffo
Alcides J M da Silva
Amartya Basu
Neerja Kaushik-Basu
Paulo R R Costa
Tanaji T Talele
P2860
P304
P356
10.1093/NAR/GKM1178
P407
P577
2008-01-18T00:00:00Z